April 2021 FDA Recall Hydrocodone Bitartrate And Homatropine Methylbromide by Kvk-tech, Inc.
D-0386-2021 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Kvk-tech, Inc. on April 27, 2021 for the product Hydrocodone Bitartrate And Homatropine Methylbromide. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0386-2021

Reason for Recall
Failed Impurities/Degradation Specifications
Initiated
04-27-2021
Reported
05-26-2021
Quantity
17,096 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distributed Nationwide in the USA
Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03

Batch or Lot Expiration Information

Lot# Lot: 15684A, Exp 7/2021